The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Surface Expression of HLA-E, an Inhibitor of Natural Killer Cells, Enhanced by Human Cytomegalovirus gpUL40
Abstract
The nonclassical major histocompatibility complex (MHC) class I molecule HLA-E inhibits natural killer (NK) cell–mediated lysis by interacting with CD94/NKG2A receptors. Surface expression of HLA-E depends on binding of conserved peptides derived from MHC class I molecules. The same peptide is present in the leader sequence of the human cytomegalovirus (HCMV) glycoprotein UL40 (gpUL40). It is shown that, independently of the transporter associated with antigen processing, gpUL40 can up-regulate expression of HLA-E, which protects targets from NK cell lysis. While classical MHC class I molecules are down-regulated, HLA-E is up-regulated by HCMV. Induction of HLA-E surface expression by gpUL40 may represent an escape route for HCMV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites
Nielsen, H., Engelbrecht, J., Brunak, S., & von Heijne, G. (1997) · Protein Engineering Design and Selection · doi:10.1093/protein/10.1.1 · Cited by 5,356
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
Braud, V. M., Allan, D. S. J., O'Callaghan, C. A., Söderström, K., D'Andrea, A., Ogg, G. S., Lazetic, S., Young, N. T., Bell, J. I., Phillips, J. H., et al. (1998) · Nature · doi:10.1038/35869 · Cited by 2,227
Self-citationSevere Herpesvirus Infections in an Adolescent without Natural Killer Cells
Biron, C. A., Byron, K. S., & Sullivan, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906293202605 · Cited by 1,269
HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
Lee, N., Llano, M., Carretero, M., Ishitani, A., Navarro, F., López-Botet, M., & Geraghty, D. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5199 · Cited by 1,053
Colonna, M., Navarro, F., Bellón, T., Llano, M., García, P., Samaridis, J., Angman, L., Cella, M., & López-Botet, M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.11.1809 · Cited by 950
Viral Strategies of Immune Evasion
Ploegh, H. L. (1998) · Science · doi:10.1126/science.280.5361.248 · Cited by 778
Borrego, F., Ulbrecht, M., Weiss, E. H., Coligan, J. E., & Brooks, A. G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.5.813 · Cited by 727
A Novel Immunoglobulin Superfamily Receptor for Cellular and Viral MHC Class I Molecules
Cosman, D., Fanger, N., Borges, L., Kubin, M., Chin, W., Peterson, L., & Hsu, M.-L. (1997) · Immunity · doi:10.1016/s1074-7613(00)80529-4 · Cited by 695
Lee, N., Goodlett, D. R., Ishitani, A., Marquardt, H., & Geraghty, D. E. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.10.4951 · Cited by 505
Braud, V., Yvonne Jones, E., & McMichael, A. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270517 · Cited by 502
Self-citationThe ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP
Ahn, K., Gruhler, A., Galocha, B., Jones, T. R., Wiertz, E. J. H. J., Ploegh, H. L., Peterson, P. A., Yang, Y., & Früh, K. (1997) · Immunity · doi:10.1016/s1074-7613(00)80349-0 · Cited by 477
Activation and function of natural killer cell responses during viral infections
Biron, C. A. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80155-0 · Cited by 420
Polić, B., Hengel, H., Krmpotić, A., Trgovcich, J., Pavić, I., Lučin, P., Jonjić, S., & Koszinowski, U. H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.6.1047 · Cited by 361
Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia.
Robertson, M. J., Cochran, K., Cameron, C. A., Le, J. M., Tantravahi, R. V., & Ritz, J. (1996) · PubMed · Cited by 343
The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells
Reyburn, H. T., Mandelboim, O., Valés-Gómez, M., Davis, D. M., Pazmany, L., & Strominger, J. L. (1997) · Nature · doi:10.1038/386514a0 · Cited by 321
A Viral ER-Resident Glycoprotein Inactivates the MHC-Encoded Peptide Transporter
Hengel, H., Koopmann, J.-O., Flohr, T., Muranyi, W., Goulmy, E., Hämmerling, G. J., Koszinowski, U. H., & Momburg, F. (1997) · Immunity · doi:10.1016/s1074-7613(00)80350-7 · Cited by 315
Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo
Farrell, H. E., Vally, H., Lynch, D. M., Fleming, P., Shellam, G. R., Scalzo, A. A., & Davis-Poynter, N. J. (1997) · Nature · doi:10.1038/386510a0 · Cited by 306
Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen.
Scalzo, A. A., Fitzgerald, N. A., Simmons, A., La Vista, A. B., & Shellam, G. R. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.5.1469 · Cited by 304
Lehner, P. J., Karttunen, J. T., Wilkinson, G. W. G., & Cresswell, P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6904 · Cited by 283
Self-citationBraud, V. M., Allan, D. S. J., Wilson, D., & McMichael, A. J. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70014-4 · Cited by 277
Self-citationScalzo, A. A., Fitzgerald, N. A., Wallace, C. R., Gibbons, A. E., Smart, Y. C., Burton, R. C., & Shellam, G. R. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.2.581 · Cited by 238
Leong, C. C., Chapman, T. L., Bjorkman, P. J., Formankova, D., Mocarski, E. S., Phillips, J. H., & Lanier, L. L. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.10.1681 · Cited by 189
Cell Types Involved in Replication and Distribution of Human Cytomegalovirus
Plachter, B., Sinzger, C., & Jahn, G. (1996) · Advances in Virus Research · doi:10.1016/s0065-3527(08)60073-1 · Cited by 176
Moins‐Teisserenc, H., Gadola, S. D., Cella, M., Dunbar, P. R., Exley, A., BLAKE, N. W., Baycal, C., Lambert, J., Bigliardi, P. L., Willemsen, M. J., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04206-3 · Cited by 141
Self-citationSignal Sequence Processing in Rough Microsomes
Lyko, F., Martoglio, B., Jungnickel, B., Rapoport, T. A., & Dobberstein, B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.34.19873 · Cited by 105
Borysiewicz, L. K., Rodgers, B. C., Morris, S., et al. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.134.4.2695 · Cited by 75
Self-citation
Cited by
Lanier, L. L. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,769
Modulation of natural killer cell activity by viruses
Lisnić, V. J., Krmpotić, A., & Jonjić, S. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.05.011 · Cited by 1,003
KIR: Diverse, Rapidly Evolving Receptors of Innate and Adaptive Immunity
Vilches, C., & Parham, P. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.092501.134942 · Cited by 986
Natural killer cells, viruses and cancer
Cerwenka, A., & Lanier, L. L. (2001) · Nature Reviews Immunology · doi:10.1038/35095564 · Cited by 875
Imprint of human cytomegalovirus infection on the NK cell receptor repertoire
Gumá, M., Angulo, A., Vilches, C., Gómez-Lozano, N., Malats, N., & López-Botet, M. (2004) · Blood · doi:10.1182/blood-2004-05-2058 · Cited by 865
Metadata
- Authors
- Tomasec, P., Braud, V. M., Rickards, C., Powell, M. B., McSharry, B. P., Gadola, S., Cerundolo, V., Borysiewicz, L. K., McMichael, A. J., & Wilkinson, G. W. G.
- Venue
- Science
- Published
- 2000-02-11
- Volume
- 287
- Issue
- 5455
- Pages
- 1031-1033
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2052667644
- Cited by
- 661
- References
- 26
- FWCI
- 12.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.